Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android

Childhood immunologic disorder characterized by pathologic proliferation of histiocytes caused by the Langerhans cells. Involves mainly the skin, bones, brain, lungs, spleen, and liver. The presence of diabetes insipidus must be considered. Presents nonmalignant growths that represent accumulation of histiocytes. Poor prognosis (70% mortality).

Letterer-Siwe Syndrome; Abt-Letterer-Siwe Syndrome; Siwe Disease.

Reported between 1:200,000 and 1:3,300,000 live births. Most cases are sporadic.

Evidence supporting both autosomal dominant and recessive inheritance in different families.

Letterer-Siwe disease (LSD) is one of the Langerhans cell histiocytoses (LCH). Physiologically, Langerhans cells detect non-self-antigens and present them to the cells of the immune system (T cells), thus allowing an appropriate immune response from the body. They are normally found in the epidermis of the skin, but in LSD they spread to bone and other tissues and become associated with eosinophils. Lesions arise in many organs, including bone, skin, spleen, liver, lungs, lymph nodes, and brain. Granulomatous inflammatory lesions develop and may proliferate and become destructive. These lesions later become less cellular, necrotic, and fibrotic.

The hallmark of LSD is the presence of pathologic Langerhans cells in involved tissues. Specific histochemical, immunologic, and protein markers have been identified (Birbeck granules or positive S-100 beta protein and CD Ia antigen). These biochemical findings in addition to multiorgan involvement help make the diagnosis.

Although LSD has been described in adult patients, it is predominantly a condition affecting children age 2 months to 3 years. Clinical features include fever, anemia, thrombocytopenia, and the manifestations of histiocyte proliferation, including skin disorders (seborrheic, eczematous, pustular or nodular lesions particularly on the scalp), lytic lesions of the bones, and splenogenic thrombocytopenia. The lungs can be involved (nonproductive cough, dyspnea, pleural effusion, interstitial pneumonitis, and spontaneous pneumothorax). Hypothalamic involvement resulting in diabetes insipidus (DI). Eye protrusion may be present. The clinical course is very variable, and spontaneous remissions have occurred. Prognosis is generally poor. Treatment may include use of glucocorticoids, chemotherapeutic agents, bone marrow transplantation, and desmopressin for DI.

Blood examination: cell blood count, platelet count must be obtained. Determine whether DI is present; evaluate electrolytes. Evidence of long bone involvement should be sought. Consider perioperative glucocorticoid coverage. A chest x-ray film should be obtained. Coagulation profile and bleeding time must be available.

Correction of anemia and thrombocytopenia may be necessary. Be vigilant for presence of DI. Care should be taken when moving patients to prevent pathologic fractures where bony lesions are present. In the presence of lung involvement, the potential for pneumothorax, and/or pleural fusion, mechanical ventilation must be used judiciously.

Perioperative glucocorticoid coverage may be necessary. Consider side effects of chemotherapeutic agents.

Histiocytosis: Rare spectrum of disorders characterized by proliferation and accumulation of histiocyte in various lesions within the body. Lesions may include Langerhans cells, monocytes, and eosinophils. Most affected individuals have single or multiple bone ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.